Bimekizimab phase 2 presented at #ACR18 with extremely impressive results for joints and skin improvement (in fact the primary outcome was ACR50!!!).... game changer? @RheumNow https://t.co/3lKkIMiSCI
Links:
Dual Neutralization of IL-17A and IL-17F with Bimekizumab in Patients with Acti…
https://acrabstracts.org/abstract/dual-neutralization-of-il-17a-and-il-17f-with…
Oct-24-2018
